• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

Introduction to 2-Chloro-6-(trifluoromethoxy)benzyl chloride (CAS No. 1261442-92-5) and Its Applications in Modern Chemical Biology

2-Chloro-6-(trifluoromethoxy)benzyl chloride, identified by the Chemical Abstracts Service Number (CAS No.) 1261442-92-5, is a highly versatile intermediate compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, featuring a chloro-substituted benzene ring coupled with a trifluoromethoxy group and a benzylic chlorine, exhibits unique chemical properties that make it invaluable in synthetic chemistry, particularly in the development of biologically active molecules.

The structural motif of 2-chloro-6-(trifluoromethoxy)benzyl chloride combines the reactivity of chloro-substituted aromatic compounds with the electron-withdrawing effect of the trifluoromethoxy group. This combination enhances its utility in various synthetic transformations, including nucleophilic aromatic substitution, cross-coupling reactions, and the introduction of benzyl protecting groups in peptide synthesis. The presence of both electron-withdrawing and electron-donating groups on the aromatic ring fine-tunes its reactivity, making it an excellent candidate for constructing complex molecular architectures.

In recent years, the demand for specialized intermediates like 2-chloro-6-(trifluoromethoxy)benzyl chloride has surged due to advancements in drug discovery and molecular biology. One of the most compelling applications of this compound is in the synthesis of small-molecule inhibitors targeting protein-protein interactions. The benzyl chloride moiety serves as a versatile handle for further functionalization, allowing researchers to attach various pharmacophores while maintaining the integrity of the core scaffold. This flexibility has been leveraged in the development of novel therapeutics for diseases such as cancer, inflammation, and neurodegenerative disorders.

Recent studies have highlighted the role of 2-chloro-6-(trifluoromethoxy)benzyl chloride in the synthesis of kinase inhibitors, which are critical in oncology research. The trifluoromethoxy group imparts metabolic stability to the resulting compounds while enhancing binding affinity to target enzymes. For instance, derivatives of this compound have been shown to effectively inhibit tyrosine kinases by modulating their active sites. The chloro-substituent on the benzene ring further facilitates further derivatization, enabling the creation of libraries of compounds for high-throughput screening.

The compound's utility extends beyond kinase inhibition; it has also been employed in developing modulators of epigenetic enzymes. Epigenetic drugs are emerging as a promising class of therapeutics for conditions where genetic mutations do not directly cause disease but rather influence gene expression patterns. 2-Chloro-6-(trifluoromethoxy)benzyl chloride serves as a key building block in synthesizing inhibitors targeting histone deacetylases (HDACs) and bromodomain-containing proteins (BRDs). These inhibitors have shown preclinical promise in treating disorders such as leukemia and Alzheimer's disease.

Another area where 2-chloro-6-(trifluoromethoxy)benzyl chloride has made significant contributions is in the field of peptidomimetics. Peptides are essential signaling molecules in biological systems, but their short half-lives and poor cell permeability limit their therapeutic potential. By incorporating benzyl protecting groups derived from this compound, researchers can enhance peptide stability and bioavailability. Furthermore, the trifluoromethoxy group can be used to introduce fluorine atoms into peptide analogs, which improves metabolic stability and pharmacokinetic properties.

The synthetic methodologies involving 2-chloro-6-(trifluoromethoxy)benzyl chloride have been refined through continuous innovation. Recent advances in transition-metal catalysis have enabled more efficient cross-coupling reactions between this intermediate and various organic substrates. For example, palladium-catalyzed Buchwald-Hartwig amination allows for the introduction of aryl or heteroaryl groups at specific positions on the benzene ring, expanding its synthetic utility. These techniques have streamlined the production of complex drug candidates while maintaining high yields and purity.

The impact of 2-chloro-6-(trifluoromethoxy)benzyl chloride on medicinal chemistry is further underscored by its role in fragment-based drug design. Fragment-based approaches involve identifying small molecular fragments that bind to target proteins with moderate affinity and then optimizing these fragments into lead compounds through iterative chemical modifications. The compound's structural features make it an ideal candidate for generating fragments with high binding energy to protein targets, facilitating rapid hit identification and lead optimization.

In conclusion, 2-chloro-6-(trifluoromethoxy)benzyl chloride (CAS No. 1261442-92-5) represents a cornerstone intermediate in modern chemical biology and pharmaceutical research. Its unique structural properties enable diverse synthetic applications across multiple therapeutic areas, including oncology, inflammation, and neurodegenerative diseases. As research continues to uncover new biological targets and synthetic methodologies, the importance of this compound is likely to grow even further, solidifying its position as an indispensable tool in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)